Chee Wui Ong

Chee Wui Ong

Auto-generated profile, based on publicly available information

Chee Wui Ong

Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2021 in Journal of Medical Internet Research
Verified
Journal Article
Open access
COChee Wui Ong
Chee Wui Ong
MTMarcus Chun Jin Tan
Marcus Chun Jin Tan
MLMichael Lam
Michael Lam
VKVictor Teck Chang Koh
Victor Teck Chang Koh
Background: Virtual reality, augmented reality, and mixed reality make use of a variety of different software and hardware, but they share three main characteristics: immersion, presence, and interaction. The umbrella term for technologies with these characteristics is extended reality. The ability of extended reality to create environments that are otherwise impossible in the real world has practical implications in the medical discipline. In ophthalmology, virtual reality simulators have become increasingly popular as tools for surgical education. Recent developments have also explored diagnostic and therapeutic uses in ophthalmology. Objective: This systematic review aims to identify and investigate the utility of extended reality in ophthalmic education, diagnostics, and therapeutics. Methods: A literature search was conducted using PubMed, Embase, and Cochrane Register of Controlled Trials. Publications from January 1, 1956 to April 15, 2020 were included. Inclusion criteria were studies evaluating the use of extended reality in ophthalmic education, diagnostics, and therapeutics. Eligible studies were evaluated using the Oxford Centre for Evidence-Based Medicine levels of evidence. Relevant studies were also evaluated using a validity framework. Findings and relevant data from the studies were extracted, evaluated, and compared to determine the utility of extended reality in ophthalmology. Results: We identified 12,490 unique records in our literature search; 87 met final eligibility criteria, comprising studies that evaluated the use of extended reality in education (n=54), diagnostics (n=5), and therapeutics (n=28). Of these, 79 studies (91%) achieved evidence levels in the range 2b to 4, indicating poor quality. Only 2 (9%) out of 22 relevant studies addressed all 5 sources of validity evidence. In education, we found that ophthalmic surgical simulators demonstrated efficacy and validity in improving surgical performance and reducing complication rates. Ophthalmoscopy simulators demonstrated efficacy and validity evidence in improving ophthalmoscopy skills in the clinical setting. In diagnostics, studies demonstrated proof-of-concept in presenting ocular imaging data on extended reality platforms and validity in assessing the function of patients with ophthalmic diseases. In therapeutics, heads-up surgical systems had similar complication rates, procedural success rates, and outcomes in comparison with conventional ophthalmic surgery. Conclusions: Extended reality has promising areas of application in ophthalmology, but additional high-quality comparative studies are needed to assess their roles among incumbent methods of ophthalmic education, diagnostics, and therapeutics.

20 February 2021 in Influenza and Other Respiratory Viruses
Verified
Journal Article
Open access
PDF file
JZJohn J. Y. Zhang
John J. Y. Zhang
Keng Siang LeeKeng Siang Lee
Keng Siang Lee
COChee Wui Ong
Chee Wui Ong
MCMae Yee Chan
Mae Yee Chan
LALi wei Ang
Li wei Ang
BYBarnaby Young
Barnaby Young
Objective The use of coronavirus disease 2019 (COVID‐19) serological testing to diagnose acute infection or determine population seroprevalence relies on understanding assay accuracy during early infection. We aimed to evaluate the diagnostic performance of serological testing in COVID‐19 by providing summary sensitivity and specificity estimates with time from symptom onset. Methods A systematic search of Ovid MEDLINE, Embase, Cochrane Central Register of Controlled Trials (CENTRAL) and PubMed was performed up to May 13, 2020. All English language, original peer‐reviewed publications reporting the diagnostic performance of serological testing vis‐à‐vis virologically confirmed SARS‐CoV‐2 infection were included. Results Our search yielded 599 unique publications. A total of 39 publications reporting 11 516 samples from 8872 human participants met eligibility criteria for inclusion in our study. Pooled percentages of IgM and IgG seroconversion by Day 7, 14, 21, 28 and after Day 28 were 37.5%, 73.3%, 81.3%, 72.3% and 73.3%, and 35.4%, 80.6%, 93.3%, 84.4% and 98.9%, respectively. By Day 21, summary estimate of IgM sensitivity was 0.872 (95% CI: 0.784‐0.928) and specificity 0.973 (95% CI: 0.938‐0.988), while IgG sensitivity was 0.913 (95% CI: 0.823‐0.959) and specificity 0.960 (95% CI: 0.919‐0.980). On meta‐regression, IgM and IgG test accuracy was significantly higher at Day 14 using enzyme‐linked immunosorbent assay (ELISA) compared to other methods. Conclusions Serological assays offer imperfect sensitivity for the diagnosis of acute SARS‐CoV‐2 infection. Estimates of population seroprevalence during or shortly after an outbreak will need to adjust for the delay between infection, symptom onset and seroconversion.

10 July 2023 in Proceedings of Singapore Healthcare
Verified
Journal Article
Open access
COChee Wui Ong
Chee Wui Ong
ZLZhiwen Joseph Lo
Zhiwen Joseph Lo
SLShanying Liang
Shanying Liang
QHQiantai Hong
Qiantai Hong
LZLi Zhang
Li Zhang
EYEnming Yong
Enming Yong
Background: Post-operative upper extremity exercise is recommended to patients with arteriovenous fistulas. It is postulated that increased blood flow to vessels improves maturation and patency rates. Recent studies favour pre-operative exercise therapy to improve the outcomes of arteriovenous fistula creation. Objectives: To investigate if pre-operative exercise therapy increases vessel diameter and maturation in patients undergoing distal arteriovenous fistula creation. Methods: 34 patients planned for radiocephalic arteriovenous fistula creation were recruited at a tertiary university hospital Vascular Surgery Unit. Patients underwent a 6-week period of self-directed daily upper extremity exercises before surgery. Patients were reviewed up to 6 months post-surgery. The primary outcome investigated was change in venous and arterial diameters following exercise intervention. The secondary outcome investigated was the primary failure rate of the newly created arteriovenous fistulas. Results: After exercise therapy, mean hand grip strength increased from 20.3 ± 6.62 kg to 21.9 ± 7.16 kg ( p=.01). There was a statistically significant increase in basilic vein diameter amongst those who demonstrated strict compliance to at least 42 days of pre-operative exercise therapy by 0.51 mm from 3.23 ± 1.09 mm to 3.74 ± 1.31 mm ( p=.03). Primary failure rate of newly created radiocephalic arteriovenous fistulas was 25% (7 of 28), comparable to our previous series of 436 distal arteriovenous fistulas created which had a failure rate of 26%. Conclusions: There was a trend of increase in vein diameters after pre-operative exercise therapy. Although not statistically significant, patients with successful arteriovenous fistula creation had longer mean completion of exercise days.

8 September 2020 in JMIR Preprints
Verified
Preprint
Open access
COChee Wui Ong
Chee Wui Ong
MTMarcus Chun Jin Tan
Marcus Chun Jin Tan
MLMichael Lam
Michael Lam
VKVictor Teck Chang Koh
Victor Teck Chang Koh
BACKGROUND Virtual reality, augmented reality, and mixed reality make use of a variety of different software and hardware, but they share three main characteristics: immersion, presence, and interaction. The umbrella term for technologies with these characteristics is extended reality. The ability of extended reality to create environments that are otherwise impossible in the real world has practical implications in the medical discipline. In ophthalmology, virtual reality simulators have become increasingly popular as tools for surgical education. Recent developments have also explored diagnostic and therapeutic uses in ophthalmology. OBJECTIVE This systematic review aims to identify and investigate the utility of extended reality in ophthalmic education, diagnostics, and therapeutics. METHODS A literature search was conducted using PubMed, Embase, and Cochrane Register of Controlled Trials. Publications from January 1, 1956 to April 15, 2020 were included. Inclusion criteria were studies evaluating the use of extended reality in ophthalmic education, diagnostics, and therapeutics. Eligible studies were evaluated using the Oxford Centre for Evidence-Based Medicine levels of evidence. Relevant studies were also evaluated using a validity framework. Findings and relevant data from the studies were extracted, evaluated, and compared to determine the utility of extended reality in ophthalmology. RESULTS We identified 12,490 unique records in our literature search; 87 met final eligibility criteria, comprising studies that evaluated the use of extended reality in education (n=54), diagnostics (n=5), and therapeutics (n=28). Of these, 79 studies (91%) achieved evidence levels in the range 2b to 4, indicating poor quality. Only 2 (9%) out of 22 relevant studies addressed all 5 sources of validity evidence. In education, we found that ophthalmic surgical simulators demonstrated efficacy and validity in improving surgical performance and reducing complication rates. Ophthalmoscopy simulators demonstrated efficacy and validity evidence in improving ophthalmoscopy skills in the clinical setting. In diagnostics, studies demonstrated proof-of-concept in presenting ocular imaging data on extended reality platforms and validity in assessing the function of patients with ophthalmic diseases. In therapeutics, heads-up surgical systems had similar complication rates, procedural success rates, and outcomes in comparison with conventional ophthalmic surgery. CONCLUSIONS Extended reality has promising areas of application in ophthalmology, but additional high-quality comparative studies are needed to assess their roles among incumbent methods of ophthalmic education, diagnostics, and therapeutics.

5 October 2026 in Eye
Verified
Journal Article
Open access
PDF file
COChee Wui Ong
Chee Wui Ong
BLBlanche Xiaohong Lim
Blanche Xiaohong Lim
SBSanjiv K. Bhatia
Sanjiv K. Bhatia
TWTjaart van der Walt
Tjaart van der Walt
TNTareq Nabhan
Tareq Nabhan
CLChris Lim
Chris Lim
The purpose of this review is to describe integrated technologies for blink analysis and their utility in evaluating ocular surface diseases. A literature search was conducted using PubMed, Embase, and CENTRAL from January 1, 2000, to August 17, 2025. Search terms included “Eye Blink”, “Blink”, “Blinking”, “Device”, “Technology”, “Appliance”, and “Application”. We included studies describing the use of integrated technologies to capture and analyse blink metrics for the evaluation of dry eye disease and other ocular surface conditions. Publications describing technical engineering aspects or technologies without evaluation of ocular surface diseases were excluded. Findings from relevant studies were extracted and compared. Of 3275 identified records, 42 met inclusion criteria. We evaluated the use of 9 technologies. These comprised desk-bound devices(Intelligent Vision Sensor, LipiView™, and IDRA) , wearable devices (Wink Glass, Blink-sensing Glasses), and smartphone or computer applications(HealthyRoad, DryEyeRhythm, Dry eye or not? and EyeScore) . LipiView™ and IDRA were most commonly studied. Blink rate and partial blink rate were the most commonly analysed parameters, and DED was the most commonly evaluated ocular surface condition. Consistent with existing literature, studies demonstrated associations between increased partial blink rates and ocular surface compromise. There was however heterogeneity in methods of blink analysis and insufficient validation of the accuracy and diagnostic ability of measured blink parameters for ocular surface conditions. Integrated blink analysis technologies are promising for the assessment of ocular surface diseases. Further studies are needed to evaluate the validity, reliability, and clinical utility of these technologies.